Report cover image

Global & Peru Cancer Therapeutics Market to 2031

Published Jun 04, 2025
Length 100 Pages
SKU # BMKS20063485

Description

Peru faces a considerable cancer burden, with the National Institute of Health identifying cancer as one of the country's primary causes of death. According to global cancer statistics, approximately 69,849 new cancer cases and 34,976 related deaths were recorded in 2020. The same data also shows that around 4,636 new colorectal cancer cases were diagnosed across all age groups. The rising number of cancer diagnoses is driving demand for effective treatment options such as chemotherapy, immunotherapy, and targeted therapies. This growing need is encouraging pharmaceutical companies to develop and expand their therapeutic portfolios to better serve cancer patients.

To improve cancer care access, the Peruvian government has launched several strategic initiatives, including the implementation of a national cancer control plan through the Instituto Nacional de Enfermedades Neoplásicas (INEN). This plan emphasizes early detection, prevention, and comprehensive treatment. As of mid-2024, Peru continues to progress toward universal health coverage for cancer patients. International support from organizations such as the MD Anderson Cancer Center has been instrumental, with their participation in the imPACT Review mission and collaboration with local experts to enhance cancer prevention, diagnosis, and treatment strategies.

Additionally, in November 2023, Adium Pharma, a partner of PharmaMar, secured full regulatory approval from Peru’s Ministry of Health to commercialize Zepzelca (lurbinectedin). This therapy is intended for adult patients with metastatic small cell lung cancer (SCLC) who have experienced disease progression following platinum-based chemotherapy.

Table of Contents

100 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Data Triangulation and Validation:
4. Peru Cancer Therapeutics Market Landscape
4.1 Overview
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
5. Cancer Therapeutics Market Key Market Dynamics
5.1 Cancer Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.3 Market Restraints
5.4 Market Opportunities
5.5 Future Trends
5.6 Impact of Drivers and Restraints
6. Peru Cancer Therapeutics Market – Analysis
6.1 Peru Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
6.2 Peru Cancer Therapeutics Market Revenue and Forecast Analysis
7. Peru Cancer Therapeutics Market Analysis – by Therapy Types
7.1 Peru Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
8. Peru Cancer Therapeutics Market Analysis – by Indications
8.1 Peru Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
9. Peru Cancer Therapeutics Market Analysis – by Distribution Channel
9.1 Peru Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.1 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.2 Partnerships and Collaborations
11.2 Other Developments
12. Company Profiles
12.1 Bristol-Myers Squibb Co
12.1. 1 Key Facts
12.1. 2 Business Description
12.1. 3 Products and Services
12.1. 4 Financial Overview
12.1. 5 SWOT Analysis
12.1. 6 Key Developments
12.2 AbbVie Inc
12.2. 1 Key Facts
12.2. 2 Business Description
12.2. 3 Products and Services
12.2. 4 Financial Overview
12.2. 5 SWOT Analysis
12.2. 6 Key Developments
12.3 Johnson & Johnson
12.3. 1 Key Facts
12.3. 2 Business Description
12.3. 3 Products and Services
12.3. 4 Financial Overview
12.3. 5 SWOT Analysis
12.3. 6 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4. 1 Key Facts
12.4. 2 Business Description
12.4. 3 Products and Services
12.4. 4 Financial Overview
12.4. 5 SWOT Analysis
12.4. 6 Key Developments
12.5 Pfizer Inc
12.5. 1 Key Facts
12.5. 2 Business Description
12.5. 3 Products and Services
12.5. 4 Financial Overview
12.5. 5 SWOT Analysis
12.5. 6 Key Developments
12.6 AstraZeneca Plc
12.6. 1 Key Facts
12.6. 2 Business Description
12.6. 3 Products and Services
12.6. 4 Financial Overview
12.6. 5 SWOT Analysis
12.6. 6 Key Developments
12.7 Merck KGaA
12.7. 1 Key Facts
12.7. 2 Business Description
12.7. 3 Products and Services
12.7. 4 Financial Overview
12.7. 5 SWOT Analysis
12.7. 6 Key Developments
12.8 Novartis AG
12.8. 1 Key Facts
12.8. 2 Business Description
12.8. 3 Products and Services
12.8. 4 Financial Overview
12.8. 5 SWOT Analysis
12.8. 6 Key Developments
12.9 Astellas Pharma Inc
12.9. 1 Key Facts
12.9. 2 Business Description
12.9. 3 Products and Services
12.9. 4 Financial Overview
12.9. 5 SWOT Analysis
12.9. 6 Key Developments
12.10 Eli Lilly and Co
12.10. 1 Key Facts
12.10. 2 Business Description
12.10. 3 Products and Services
12.10. 4 Financial Overview
12.10. 5 SWOT Analysis
12.10. 6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
TABLE OF TABLES
Table 1. Peru Cancer Therapeutics Market Segmentation
Table 2. List of Vendors
Table 3. Peru Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
Table 4. Peru Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 5. Peru Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
Table 6. Peru Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
Table 7. Peru Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 8. Peru Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 9. Peru Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
Table 10. Peru Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
Table 11. List of Abbreviations
TABLE OF FIGURES
Figure 1. Impact Analysis of Drivers and Restraints
Figure 2. Peru Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
Figure 3. Heat Map Analysis by Key Players
Figure 4. Company Positioning and Concentration

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.